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The impact of intensive multifactorial treatment on
perceptions of chronic care among individuals with
screen-detected diabetes: results from the
ADDITION-Denmark trial
L. Kuznetsov,1 R. K. Simmons,1 A. Sandbaek,2 H. T. Maindal2,3
SUMMARY
Objectives: To describe perceptions of chronic care among diabetes patients
6 years after diagnosis by screening and to examine the impact of intensive treat-
ment on patients’ perceptions of chronic care. Methods: The ADDITION-Denmark
(2001–2006) trial compared the effects of intensive multifactorial therapy (IT) with
routine care (RC) among individuals with screen-detected diabetes. Perceptions of
chronic care were assessed using the Patient Assessment of Chronic Illness Care
(PACIC) measure after 6-year follow-up (n = 937). Analysis was by intention-to-
treat, accounting for clustering by general practice. Results: The mean (SD) sum-
mary PACIC score was 2.4 (0.79) in the RC and 2.4 (0.82) in the IT group. The
highest mean (SD) PACIC subscale score was for Delivery System Design/Decision
Support [RC: 3.2 (0.95), IT: 3.3 (0.91)] and the lowest was for Follow-up/Coordi-
nation [RC: 2.1 (0.84), IT: 2.1 (0.87)]. Perceptions of chronic care did not differ
between trial groups. Conclusions: Compared to RC, an intensive multifactorial
intervention was not associated with differences in perceptions of chronic care
among patients with screen-detected diabetes after 6 years. Intensive treatment
does not adversely affect perceptions of chronic care early in the course of the dis-
ease. However, there is potentially room for improvement in some aspects of
chronic care.
What’s known
There have been recent concerns about the intensity
of diabetes treatment in clinical practice. This might
be particularly pertinent for asymptomatic individuals
found earlier in the disease trajectory, for who the
burden of treatment might be higher than the burden
of disease.
What’s new
We assessed the impact of intensive treatment on
perceptions of care in screen-detected diabetes
patients 6 years after diagnosis. Our results suggest
that perceptions of care did not differ between the
intensive and routine care groups. This result should
reassure family doctors and other health practitioners
that they can intensively treat patients found to have
screen-detected diabetes without any adverse effects
on perceptions of chronic care.
Background
Type 2 diabetes is a chronic condition, which is lar-
gely treated in primary care settings across Europe,
with inconsistencies in the quality of diabetes care
between and within countries (1). The management
of diabetes is largely dependent on self-care and 95%
of diabetes management happens outside clinics,
beyond providers’ awareness and without direct pro-
vider influence (2). Previous research has demon-
strated the efficacy of lifestyle and diet modification
(3,4) and diabetes treatment adherence (5) for sec-
ondary prevention in diabetes. Supporting and
improving self-management and self-care in people
with diabetes can therefore help prevent complica-
tions, slow progression of the disease, enhance
health-related quality of life, and reduce the eco-
nomic burden of the disease on health care systems.
The Chronic Care Model (CCM) provides a con-
ceptual framework to improve care for chronically ill
patients (6,7). The implementation of the CCM or
its elements in diabetes care improves clinical param-
eters and chronic care, and in some cases, reduces
health care costs (8,9). Some authors have argued
that patient perceptions of care and views on service
delivery should be seen as indicators of quality of
care and thus be included in quality assessment
(10,11). There is evidence that the quality of diabetes
care is positively associated with patient satisfaction
with provider of care (12) and that patient satisfac-
tion with primary care is associated with improved
diabetes outcomes (13).
There have been recent concerns about the inten-
sity of diabetes treatment (14). This might be partic-
ularly pertinent for asymptomatic individuals found
earlier in the disease trajectory, for who the burden
of treatment might be higher than the burden of dis-
ease. The number of individuals found and treated
early is expected to increase with the advent of
national screening programmes (15). It is therefore
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important to assess the potential impact of intensive
treatment on perceptions of care among screen-
detected individuals.
Using data from ADDITION-Denmark, a cluster
randomised controlled trial comparing intensive
multifactorial treatment with routine care (RC)
among patients with screen-detected type 2 diabetes,
we aimed to (i) describe patients’ perceptions of
chronic care, (ii) examine the predictors of percep-
tions of chronic care, and (iii) examine the impact
of intensive multifactorial treatment on perceptions
of chronic care at 6-years post-diagnosis.
Methods
The design and rationale of the Anglo-Danish-Dutch
Study of Intensive Treatment in People with Screen
Detected Diabetes in Primary Care (ADDITION-
Europe) Study have been reported (16). The current
analysis includes data taken exclusively from 6-year
follow-up of the Danish arm of the ADDITION-
Europe trial. In brief, the ADDITION-Denmark
consists of two phases: a primary care based screening
programme and a pragmatic, cluster randomised,
parallel group trial comparing the effects of intensive
multifactorial therapy (IT) with RC among individu-
als with screen-detected type 2 diabetes. Screening
was undertaken between 2001 and 2006. 190 general
practices in five regions in Denmark were randomly
assigned to screening of registered patients aged
40–69 years without known diabetes followed by RC
of diabetes or screening followed by IT. Patients were
excluded if they had an illness with a life expectancy
of less than 12 months, a psychological disorder,
were housebound, pregnant or lactating. Overall,
1533 (RC = 623, IT = 910) eligible participants par-
ticipated in the treatment phase of the ADDITION-
Denmark study. Ethical approval of the study was
attained from the local Science Ethics Committee of
Aarhus County, Denmark (protocol no.: 20000183).
The Danish Data Surveillance Authority permitted
the collection and storage of data (journal no: 2000-
41-0042). All participants provided informed consent.
ADDITION-Europe is registered as NCT00237549.
Intervention
Individuals were treated according to the group to
which their practice was allocated: RC or IT. Details
have been described previously (16,17). Intensifica-
tion of treatment included funding for practices to
facilitate more frequent contact and theory based
diabetes education materials for participants. Family
doctors were encouraged to introduce a stepwise tar-
get-led drug treatment regime to reduce hyperglyca-
emia, hypertension and hyperlipidaemia based on the
Steno-2 study (18). For the RC group, physicians
were only provided with diagnostic test results and
patients received standard diabetes care according to
local recommendations (19).
Measures
ADDITION-Denmark health assessments included
physiological and anthropometric measurements,
venesection and the completion of questionnaires at
baseline and 6-years post-diagnosis. Data collection
methods have been described previously (16,20).
Anthropometric and clinical measurements were
undertaken by trained staff who were blind to study
group following standard operating procedures.
HbA1c was analysed by DCCT aligned ion-exchange
high-performance liquid chromatography using
Tosoh G7 machines. Socio-demographic information
[age, sex, age when completed full-time education
(≤ 19 years or > 19 years of age)], lifestyle behav-
iours [smoking status (non-smoker/ex-smoker or
current smoker), alcohol consumption [those who
meet the guidelines on alcohol consumption and
those who did not (men: ≤ 21 units/week or > 21
units/week; women: ≤ 14 units/week or > 14 units/
week)], history of angina and/or myocardial infarc-
tion and/or stroke (yes/no), and intake of glucose-,
hypertension- and lipid-lowering drugs and aspirin
(yes/no) was collected using standardised self-report
questionnaires. Physical activity was assessed using
the validated International Physical Activity Ques-
tionnaire (IPAQ) and coded into low, medium and
high categories according to published guidelines
(21).
Patient perceptions of chronic care were assessed
using the 20-item Patient Assessment Chronic Illness
Care (PACIC) questionnaire (22,23), which is based
on the CCM (24,25). It assesses the receipt of
patient-centred care and emphasizes the key elements
of modern self-management support such as collabo-
rative goal settings, problem-solving and follow-up,
and planned, proactive, and population-based care
(23). The PACIC includes five subscales on a 5-point
scale [range 1 (never) to 5 (always)] related to
patient perceptions of chronic illness care: Patient
Activation, Delivery System Design/Decision Support,
Goal Setting/Tailoring, Problem Solving/Contextual,
and Follow-up/Coordination. Each subscale is scored
by averaging the items completed within that scale.
The summary PACIC score is computed by averaging
scores across all 20 items (23). The PACIC scores
range from 1 to 5 with higher scores indicating
patient’s perception of a greater involvement in self-
management and receipt of chronic illness care deliv-
ery (22,23). Cronbach’s alpha for the overall PACIC
score was 0.89.
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Statistical analyses
Six year descriptive characteristics, including the
PACIC measure, were summarised separately by trial
group. We reported means (SD) for approximately
normally distributed continuous variables, median
(IQR) for skewed continuous variables and number
(%) for categorical variables. Differences in base-
line characteristics between participants who were
included in the analysis and those who were not were
compared using the v2 test for categorical data and
the t-test or Mann–Whitney U for continuous data.
An HbA1c level of < 7% was defined as good blood
glucose control (26). Overweight was defined as body
mass index (BMI) ≥ 25 kg/m2 and obesity as BMI
≥ 30 kg/m2 (27). Raised systolic blood pressure
was defined as ≥ 140 mmHg and raised total choles-
terol as ≥ 5.0 mmol/l (28). We used univariable linear
regression to examine the cross-sectional association
between the summary PACIC score (dependent vari-
able) and socio-demographic characteristics, cardio-
vascular risk factors, medication intake, and lifestyle
variables. The summary PACIC score and PACIC
subscales were analysed with normal errors regression
in an intention-to-treat analysis. We took account of
clustering (by GP practice) by including a robust stan-
dard error term in the model. All regression results are
presented as unstandardised b-coefficients with their
95% confidence intervals. Statistical significance was
set at p < 0.05. Statistical analyses were performed
using SPSS for Windows 19.0 (SPSS, Inc., Chicago, IL).
Results
Of those alive at 6-year follow-up, 1277/1416 (90.2%)
ADDITION-Denmark participants attended a health
assessment at a local clinical research facility; complete
PACIC data were available for 937 participants. Indi-
viduals who were included in the analysis (n = 937)
were slightly younger (59.6 vs. 60.4 years respectively)
and included more men (59% vs. 54%) at baseline
than those who were not included (n = 596). Both
trial groups were similar for baseline BMI, HbA1c,
total cholesterol and systolic blood pressure.
Participant characteristics at the 6-year follow-up
are presented in Table 1. In both trial groups, the
mean age of participants was 66 years and average
diabetes duration was 5.9 years. Fewer participants in
the RC group (67.1%) had completed their full-time
education >19 years compared to the IT group
(75.4%). On average, the cohort was obese [RC:
mean BMI 30.6 (5.3) kg/m2, IT: mean BMI 30.7
(5.4) kg/m2), with slightly elevated systolic blood
pressure (RC: 135.9 (18.02) mmHg, IT: 133.9
(17.05) mmHg] and good glycaemic control [RC:
mean HbA1c: 6.5% (0.82), IT: mean HbA1c: 6.5%
(0.85)]. A significant proportion of participants were
current smokers (RC: 23.5%; IT: 21.1%). A higher
proportion of participants in the IT group were pre-
scribed cardio-protective medication compared to
the RC group.
Perceptions of chronic care
At the 6-year health assessment, the PACIC item
‘Satisfied that my care was well organized’ achieved
the highest mean score (SD) in both groups [RC: 3.9
(1.09), IT: 4.0 (1.01)], and the PACIC item ‘Encour-
aged to attend programs in the community that
could help me’ had the lowest mean score in the RC
[1.5 (0.92)] and IT group [1.7 (1.06)] (Table 2). The
PACIC mean subscale scores were similar in both
trial groups: the highest average score was for ‘Deliv-
ery System Design/Decision Support’ [RC: 3.2 (0.95),
IT: 3.3 (0.91)] and the lowest average score was for
‘Follow-up/Coordination’ [RC: 2.1 (0.84), IT: 2.1
(0.87)]. The mean summary PACIC score was 2.4
(0.81) in the overall cohort, and 2.4 (0.79) in the RC
and 2.4 (0.82) in the IT group.
Predictors of perceptions of chronic care
There was no association between the majority of
socio-demographic characteristics, cardiovascular risk
factors, medication intake and lifestyle behaviour
variables with the summary PACIC score at 6 year
follow-up (Table 3). However, participants with
raised total cholesterol reported a lower summary
PACIC score [b = 0.18 (0.31, 0.06)] and partici-
pants taking glucose-lowering drugs reported a higher
summary PACIC score [b = 0.14 (0.02, 0.26)].
Impact of intensive multifactorial treatment on
perceptions of chronic care
There was no difference in the summary PACIC
score between the trial groups [b = 0.07 (0.06,
0.20)] nor between the PACIC subscales and trial
group (Table 4). The difference in PACIC scores was
highest for the Delivery System Design/Decision
Support sub-scale (b = 0.11) and lowest for the
Problem-solving/Contextual Counselling sub-scale
(b = 0.04); however, none of the differences reached
statistical significance.
Discussion
Compared to RC, an intensive multifactorial inter-
vention was not associated with differences in
perceptions of chronic care among patients with
screen-detected diabetes after a mean follow-up of
6 years. Most participants in the RC and the IT
groups reported that they were satisfied that their
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care was well organised. While our findings suggest
that intensive treatment does not adversely affect
perceptions of chronic care early in the course of the
disease, the overall mean summary PACIC score was
quite low.
The mean summary PACIC score [RC: 2.4 (0.79),
IT: 2.4 (0.82)] and some of the PACIC mean sub-
scales [ranging from 2.1 (0.84) to 3.2 (0.95) in the
RC group and from 2.1 (0.87) to 3.3 (0.91) in the IT
group] in ADDITION-Denmark were lower com-
pared to previous studies examining perceptions of
chronic care among patients with diabetes. For
example, in a Dutch cohort of diabetes patients
(mean age 69 years), the mean summary PACIC
score was 3.2 (1.0) and PACIC subscale scores
ranged from 2.0 (0.8) to 3.9 (1.1) (29). A higher
average summary PACIC score [3.2 (0.9)] was also
reported in American (mean age 64 years) (22) and
in Spanish-speaking diabetes patients (mean age
64 years) [3.2 (0.8)] (30). In contrast to these
studies, ADDITION-Denmark participants were
screen-detected and largely asymptomatic. As such,
our participants did not have had long-term experi-
ence of engaging with chronic care delivery services,
and may have reported lower perceptions of care
than the cohorts of clinically diagnosed patients
described above. Among ADDITION-Denmark par-
ticipants the PACIC subscale ‘Delivery System
Design/Decision Support’ [RC: 3.2 (0.95), IT: 3.3
(0.91)] was rated most highly, which is in line with
previous studies (mean score raging from 3.3 (0.9)
(31) to 3.9 (1.1) (29) or 3.95 (0.98) (30).
The aim of the CCM is to encourage informed,
activated patients to interact with a proactive and
prepared practice team (7). The PACIC instrument
offers direct guidance on which components of
chronic care could be improved. For example, in our
cohort, individual Goal-Setting/Tailoring and Follow-
up/Coordination of diabetes patients could be
improved. Participants also reported low scores for
Table 1 Participant characteristics in the ADDITION-Denmark study 6 years after diagnosis
Category Characteristics Total n Routine care Intensive treatment
Patients 937 39.7 (372) 60.3 (565)
Diabetes duration (years) 937 5.9 (1.34) 5.9 (1.39)
Socio-demographics Age (years) 937 65.6 (6.7) 65.5 (6.9)
Male sex*, % (n) 937 59.1 (220) 59.1 (334)
Full-time education completed at > 19 years, % (n) 835 67.1 (228) 75.4 (373)
Caucasian ethnicity*, % (n) 933 97.8 (353) 98.5 (528)
Cardiovascular risk factors HbA1c (%) 933 6.5 (0.82) 6.5 (0.85)
HbA1c < 7% 933 79.0 (293) 80.0 (454)
BMI (kg/m2) 937
Men 554 30.2 (4.46) 30.4 (4.61)
Women 383 31.3 (6.30) 31.3 (7.04)
Systolic blood pressure (mmHg) 936 135.9 (18.02) 133.9 (17.05)
Total cholesterol (mmol/l) 935 4.4 (0.81) 4.2 (0.94)
History of angina and/or myocardial infarction
and/or stroke, % (n)
899 15.0 (54) 16.7 (90)
Medication intake Glucose-lowering drugs, % (n) 936 52.2 (194) 63.1 (356)
Hypertension-lowering drugs, % (n) 936 73.4 (273) 81.2 (458)
Lipid-lowering drugs, % (n) 936 76.9 (286) 83.0 (468)
Aspirin, % (n) 936 44.4 (165) 77.3 (436)
Lifestyle Current smoker, % (n) 924 23.5 (86) 21.1 (118)
Alcohol consumption, % (n) 913
Men (≤ 21 units/week) 540 81.7 (174) 85.6 (280)
Women (≤ 14 units/week) 373 94.6 (141) 92.4 (207)
Alcohol consumption (units per week)† 913 5.0 (1.0; 13.0) 4.0 (1.0; 12.0)
Physical activity‡, % (n) 908
Low 153 17.5 (63) 16.4 (90)
Moderate 263 26.4 (95) 30.7 (168)
High 492 56.1 (202) 52.9 (290)
Values are means (SD) or % (n) unless stated otherwise; BMI, body-mass index; HbA1c, glycosylated haemoglobin. *Measured at
baseline, †median (25th; 75th percentile); ‡physical activity was assessed using the validated International Physical Activity
Questionnaire (IPAQ).
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the item: ‘encouraged to attend programs in the
community’. This information could be useful for
health planners in Denmark and elsewhere in order
to achieve a coordinated health system.
In terms of predictors of perceptions of chronic
care, our results are in broad agreement with previ-
ous studies, which report few associations between
various patient or medical characteristics and the
PACIC measure. Aragones et al. reported no signifi-
cant associations between socio-demographic (e.g.
age, education, years living in the US) characteristics
and the summary PACIC score in Spanish-speaking
diabetes patients in the US (30). The results of a US
study among type 2 diabetes patients showed that
the summary PACIC score was significantly associ-
ated with the quality of diabetes care received and
with physical activity level but was unrelated to
patient characteristics (22). Taggart et al. found that
the summary PACIC score was positively related to
having good or very good health over the last
12 months, whereas having a degree/diploma, being
employed, retired, married/cohabiting, type and
duration of chronic conditions had negative effect on
the total PACIC score (32). We found that partici-
pants with raised total cholesterol reported a lower
summary PACIC score, while participants taking
glucose-lowering drugs reported a higher summary
PACIC score. This suggests that patients who were
being treated for their raised cardiovascular risk
factor levels reported higher perceptions of chronic
care delivery. This supports our conjecture that
individuals who engage with health services have
higher perceptions of chronic care than those who
do not. The relationship between patient perceived
Table 2 Results for the summary PACIC score, subscales and individual items in the ADDITION-Denmark study
6 years after diagnosis (n = 937)
PACIC* Routine care Intensive treatment
Individual PACIC items
1. Asked for my ideas when we made a treatment plan 2.3 (1.18) 2.4 (1.21)
2. Given choices about treatment to think about 1.9 (1.06) 2.1 (1.17)
3. Asked to talk about any problems with my medicines or their effects 2.6 (1.40) 2.6 (1.34)
4. Given a written list of things I should do to improve my health 2.2 (1.30) 2.4 (1.30)
5. Satisfied that my care was well organized 3.9 (1.09) 4.0 (1.01)
6. Shown how what I did to take care of my illness influenced my condition 3.4 (1.25) 3.5 (1.19)
7. Asked to talk about my goals in caring for my illness 2.4 (1.28) 2.5 (1.30)
8. Helped to set specific goals to improve my eating or exercise 2.6 (1.27) 2.6 (1.26)
9. Given a copy of my treatment plan 1.7 (1.17) 1.8 (1.21)
10. Encouraged to go to a specific group or class to help me cope with my chronic illness 1.7 (1.14) 1.7 (1.16)
11. Asked questions, either directly or on a survey, about my health habits 2.5 (1.29) 2.5 (1.26)
12. Sure that my doctor or nurse thought about my values and my traditions when they
recommended treatments
3.5 (1.35) 3.4 (1.37)
13. Helped to make a treatment plan that I could do in my daily life 2.2 (1.34) 2.3 (1.39)
14. Helped to plan ahead so I could take care of my illness even in hard times 2.1 (1.25) 2.2 (1.30)
15. Asked how my chronic illness affects my life 2.3 (1.30) 2.3 (1.27)
16. Contacted after a visit to see how things were going 1.7 (1.08) 1.7 (1.12)
17. Encouraged to attend programs in the community that could help me 1.5 (0.92) 1.7 (1.06)
18. Referred to a dietician, health educator, or counsellor 2.1 (1.34) 2.0 (1.28)
19. Told how my visits with other types of doctors, like an eye doctor or surgeon,
helped my treatment
2.8 (1.49) 3.0 (1.45)
20. Asked how my visits with other doctors were going 2.2 (1.39) 2.3 (1.44)
PACIC subscales
Patient Activation 2.3 (1.01) 2.4 (1.06)
Delivery System Design/Decision Support 3.2 (0.95) 3.3 (0.91)
Goal Setting/Tailoring 2.2 (0.94) 2.2 (0.93)
Problem Solving/Contextual 2.5 (1.05) 2.6 (1.08)
Follow-up/Coordination 2.1 (0.84) 2.1 (0.87)
Summary PACIC score 2.4 (0.79) 2.4 (0.82)
Male 2.4 (0.76) 2.5 (0.78)
Female 2.3 (0.84) 2.4 (0.88)
Values are means (SD); *Source: Glasgow et al. (23).
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quality of care and health outcomes can be bilateral:
perceived good care or satisfaction with care may be
associated with better health outcomes (13), for
example, through medical compliance (33) and loy-
alty to physicians (34). On the other hand, improved
health outcomes may be associated with increased
satisfaction of care.
There was no difference in perceptions of chronic
care between individuals receiving RC and intensive
treatment in the ADDITION-Denmark trial. The trial
was undertaken during a time when targets for cho-
lesterol and blood pressure levels became stricter for
diabetes patients. This resulted in smaller than
expected differences between the treatment groups
for cardiovascular risk factors, prescribed medication
and cardiovascular disease outcomes (17). The largest
differences between groups were observed early in
the course of the trial, and 1-year differences in car-
diovascular risk factors between the groups were not
maintained at 5 years (35,36). The intervention was
associated with a non-significant 17% reduction in
cardiovascular events over 5 years (17). The lower
than expected CVD event rate in the ADDITION
trial suggests that the 5 year duration of follow-up
may be insufficient to detect a potential difference
between groups. Event rates appeared to diverge
from 4 years suggesting that further follow up of this
trial is justified to examine whether early intensive
multifactorial treatment reduces cardiovascular risk
in the long term as seen in the UKPDS. At the cur-
rent time, health practitioners should consider treat-
ing multiple cardiovascular risk factors early and
intensively in the diabetes disease trajectory, where
the rate of CVD risk progression may be slowed
(37). Given the overall trial results the potential for
observing differences in perceptions of chronic care
between the two study groups in the current trial
may have been reduced. Our findings are in line with
the main ADDITION-Europe trial (38), where there
were no clinically significant differences in a range of
Table 3 Univariable association between the summary PACIC score and socio-demographic characteristics,




b-coefficients (95% CI) p-value
Socio-demographics
Age (years) 937 0.002 (0.01 to 0.01) 0.558
Sex (men = 0) 937 0.03 (0.14 to 0.08) 0.607
Full-time education completed at > 19 years (=0) 835 0.03 (0.14 to 0.09) 0.643
Cardiovascular risk factors
HbA1c (%) (continuous) 933 0.05 (0.02 to 0.11) 0.140
BMI (kg/m2) (continuous) 937 0.002 (0.01 to 0.01) 0.742
Systolic blood pressure (mmHg) (continuous) 936 0.002 (0.01 to 0.001) 0.134
Total cholesterol (mmol/l) (continuous) 935 0.09 (0.15 to 0.03) 0.002
HbA1c (< 7% = 0) 933 0.05 (0.07 to 0.18) 0.410
BMI (<25 kg/m2 = 0) 937 0.02 (0.13 to 0.17) 0.830
Systolic blood pressure (< 140 mmHg = 0) 936 0.05 (0.15 to 0.06) 0.360
Total cholesterol (< 5 mmol/l = 0) 935 0.18 (0.31 to 0.06) 0.004
Cardiovascular history
History of angina and/or myocardial infarction and/or stroke (no = 0) 899 0.04 (0.21 to 0.14) 0.692
Medication intake
Glucose-lowering drugs (no = 0) 936 0.14 (0.02 to 0.26) 0.023
Hypertension-lowering drugs (no = 0) 936 0.03 (0.08 to 0.14) 0.599
Lipid-lowering drugs (no = 0) 936 0.08 (0.05 to 0.21) 0.213
Aspirin (no = 0) 936 0.09 (0.02 to 0.20) 0.127
Lifestyle behaviours
Smoking status (non-/ex-smoker = 0) 924 0.05 (0.07 to 0.17) 0.419
Alcohol consumption (according to guidelines = 0) 913 0.09 (0.22 to 0.04) 0.187
Physical activity (high = 0) 908
Low 0.11 (0.24 to 0.02) 0.087
Moderate 0.01 (0.14 to 0.13) 0.942
Values are unstandardised b-coefficients (95% confidence interval); models are adjusted for standard error by computing a cluster
robust standard error for GP practice.
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patient-reported outcome measures between treat-
ment groups after 6 years of follow-up.
Study strengths include the randomised trial
design, the large sample of screen-detected diabetes
patients, and the examination of a wide range of
potential predictors of perceptions of chronic care.
90% of participants returned for a follow-up health
assessment at 6 years. However, there are a number
of limitations in our study. The sample was largely
Caucasian and middle-aged, which restricts generaliz-
ability to other populations. There were a few differ-
ences between individuals who were included in the
analysis and those who were not. However, these dif-
ferences were small and not in one direction, so are
unlikely to affect the outcome. Patients’ self-reported
behaviours may have been influenced by recall and
social desirability bias. The PACIC measure was not
available in the whole ADDITION-Europe cohort and
was not measured at baseline, so we could not inves-
tigate change over time. However, individuals were
not in receipt of chronic care delivery at baseline so
this examination was not possible. Finally, we
explored a number of possible predictors of percep-
tions of chronic care and conducted multiple signifi-
cance tests, which mean that our results should be
interpreted with caution as some significant associa-
tions may have occurred by chance.
Conclusions
Compared to RC, intensive multifactorial treatment
was not associated with differences in perceptions of
chronic care among patients with screen-detected
diabetes over 6 years. While it remains uncertain
whether early intensive treatment reduces cardiovas-
cular events, our findings suggest that such treatment
does not adversely affect perceptions of chronic care
early in the course of the disease. The results should
reassure family doctors and other health practitioners
that they can intensively treat patients found to have
screen-detected diabetes without any adverse effects
on perceptions of chronic care. The low overall score
suggests that there is potentially room for improve-
ment in some aspects of chronic care.
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Table 4 Univariable association between the summary
PACIC score, PACIC subscales and trial group in the
ADDITION-Denmark study 6 years after diagnosis
(n = 937)
Trial group




Summary PACIC score 0.07 (0.06 to 0.20) 0.263
PACIC subscales
Patient Activation 0.10 (0.05 to 0.26) 0.202
Delivery System Design/
Decision Support
0.11 (0.03 to 0.26) 0.129
Goal Setting 0.05 (0.09 to 0.19) 0.482
Problem-solving/Contextual
Counselling
0.04 (0.12 to 0.20) 0.602
Follow-up/Coordination 0.08 (0.05 to 0.22) 0.216
Values are unstandardised b-coefficients (95% confidence
interval); models are adjusted for standard error by computing
a cluster robust standard error for GP practice.
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